Fine scale spatial investigation of multiple insecticide resistance and underlying target-site and metabolic mechanisms in Anopheles gambiae in central Côte d’Ivoire by Oumbouke, Welbeck Achille et al.
Fine scale spatial investigation of multiple insecticide resistance and underlying target-1 
site and metabolic mechanisms in Anopheles gambiae in central Côte d’Ivoire 2 
Welbeck A. Oumbouke1,2*, Patricia Pignatelli3, Antoine M.G. Barreaux4,5, Innocent Z. Tia2, 3 
Alphonsine A. Koffi2, Ludovic P. Ahoua Alou2, Eleanore D. Sternberg5, Matthew B. Thomas5, David 4 
Weetman† 3 and Raphael N’Guessan† 1,2 5 
1. Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK. 6 
2. Institut Pierre Richet (IPR)/Institut National de Santé Publique (INSP), Bouaké, Côte d’Ivoire 7 
3. Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, 8 
Liverpool, UK 9 
4. School of Biological Sciences, University of Bristol, Bristol, UK. 10 
5. Department of Entomology, Center for Infectious Disease Dynamics, The Pennsylvania State 11 
University, University Park, PA 16802, USA. 12 
 13 
* Correspondence: welbeck.oumbouke@lshtm.ac.uk 14 
† These authors contributed equally 15 
 16 
Abstract 17 
Routine monitoring of occurrence, levels and mechanisms of insecticide resistance informs 18 
effective management strategies, and should be used to assess the effect of new tools on 19 
resistance. As part of a cluster randomised control trial evaluating a novel insecticide-based 20 
intervention in central Côte d’Ivoire, we assessed resistance and its underlying mechanisms in 21 
Anopheles gambiae populations from a subset of trial villages. Resistance to multiple insecticides 22 
in An. gambiae s.s. and An. coluzzii was detected across villages, with dose-response assays 23 
demonstrating extremely high resistance intensity to the pyrethroid deltamethrin (>1500-fold), 24 
and mortality following exposure to pyrethroid-treated bednets was low (<30% mortality in cone 25 
bioassays). The 1014F kdr mutation was almost fixed (>90%) in all villages but the 1575Y kdr-26 
amplifying mutation was relatively rare (<15%). The carbamate and organophosphate 27 
resistance-associated Ace-1 G119S mutation was also detected at moderate frequencies (22-28 
43%). Transcriptome analysis identified overexpression of P450 enzymes known to metabolise 29 
pyrethroids (CYP9K1, CYP6P3, and CYP6M2), and also a carboxylesterase (COEAE1F) as major 30 
candidates. CYP6P3 expression was high but variable (up to 33-fold) and correlated positively 31 
with deltamethrin resistance intensity across villages (r2=0.78, P = 0.02). Tools and strategies to 32 
mitigate the extreme and multiple resistance provided by these mechanisms are required in this 33 
area to avoid future control failures.  34 
 35 
Background 36 
Insecticide-based control methods continue to play a crucial role in reducing vector-borne 37 
diseases. Insecticides are deployed against malaria mosquitoes most commonly via long lasting 38 
insecticidal nets (LLINs) and indoor residual spraying (IRS). The significant increase in coverage 39 
with LLINs over the past 20 years has been associated with a marked reduction in malaria 40 
burden1. However, recent estimates suggest that progress has stalled, with insecticide resistance 41 
likely one of the major contributing factors. Whilst selection from other sources, especially 42 
agriculture2, may be important in some areas, there is evidence that the wide scale use of IRS and 43 
particularly LLINs is contributing to selection for pyrethroid resistance in major African vectors 44 
of malaria3. Resistance to pyrethroids is likely to increase further over the coming years, given 45 
that pyrethroids remain an important component of all currently available bednets, including 46 
newer dual-action LLINs4–6. 47 
 48 
Until recently, only four classes of insecticides (pyrethroids, organochlorines, carbamates and 49 
organophosphates) were licenced for use to control adult mosquito vectors. The pyrrole 50 
insecticide, chlorfenapyr, and the neonicotinoid, clothianidin, have recently been added to this 51 
list and are deployed either alone (for IRS) or in combination with pyrethroids (for LLINs)7–9. 52 
Except for these new insecticide classes, resistance to all currently available insecticides has been 53 
documented in Anopheles mosquito species across much of sub-Saharan Africa10–14. The best 54 
known mechanisms conferring resistance to insecticides are target site modification and 55 
increased detoxification. Substitutions in the para voltage-gated sodium channel (VSGC) ─ the 56 
target site for pyrethroids and DDT15–17 (L1014F and L1014S) ─ are widespread in An. gambiae 57 
and confer knock down resistance (kdr), with a third variant (N1575Y)17 capable of amplifying 58 
resistance where present18. A further mutation (G119S) in acetylcholinesterase (Ace-1) causes 59 
resistance to organophosphate and carbamate insecticides, which target this enzyme19–21. The 60 
G119S mutation is associated with a fitness cost in the absence of insecticides22 but Ace-1 gene 61 
duplication, coupling resistant and susceptible alleles, or multiple resistant alleles on the same 62 
chromosome, has emerged in Anopheles gambiae mosquitoes to offset deleterious effects23.  63 
Metabolic resistance arises from enhanced detoxification of insecticides. Three classes of 64 
metabolic enzymes, carboxylesterases (COEs), glutathione-S-transferases (GSTs) and 65 
cytochrome P450s have been linked with resistance in various species of mosquitoes, with the 66 
latter most frequently implicated in metabolism of pyrethroids and carbamates10,24–26. 67 
Overexpression of several P450s has been associated with insecticide resistance, but relatively 68 
few have been validated as metabolizers in vitro, and thus only these can be regarded definitively 69 
as candidates capable of causing resistance. Notably, CYP6M2, CYP6P3 and CYP9K1 have all been 70 
validated not only as pyrethroid-metabolizers but also of unrelated insecticides (DDT, bendiocarb 71 
and pyriproxyfen, respectively) demonstrating how the substrate flexibility of some P450s can 72 
cause cross-resistance by metabolizing insecticides from diverse classes10,27,28. 73 
 74 
Here we report on a study aimed at evaluating the current status of insecticide resistance in 75 
malaria vectors in central Côte d’Ivoire. Previous research has shown that Anopheles malaria 76 
vectors in Côte d’Ivoire have developed resistance to all of the four traditional classes of 77 
approved adulticides21,29,30. Resistance mechanisms detected in Côte d’Ivoire to date include kdr 78 
and Ace-1 (mutation and duplication)29 and, in An. coluzzii from the southern part of the 79 
country, overexpression of P450 genes, especially Cyp6M2 and Cyp6P3 10. However, information 80 
on resistance intensity and a comprehensive assessment of the genetic mechanisms driving 81 
resistance in An. gambiae is lacking (and especially for central Côte d’Ivoire). The present study 82 
was thus conducted prior to the onset of a cluster randomized controlled trial (CRT) of the 83 
In2Care EaveTube 31, to characterize insecticide resistance across a subset of villages and 84 
provide a baseline against which future changes may be measured through the course of the 85 
CRT. 86 
Results 87 
Insecticide resistance and LLIN efficacy 88 
Mortality rates of An. gambiae s.l. exposed to WHO diagnostic doses of deltamethrin, cyfluthrin, 89 
and bendiocarb were generally quite low with most villages below 50% (Fig. 1), and lower still 90 
for DDT (<15%). Mortality results for the two pyrethroids were strongly correlated across 91 
villages (Spearman’s ρ = 0.98, n = 8, P < 0.001), and each was also positively correlated with 92 
bendiocarb mortalities, though neither significantly (maximum ρ = 0.64, minimum P = 0.09). 93 
There was significant variation among villages in bioassay mortalities for each insecticide, though 94 
there was no difference between groups of villages comprising the study arms for any insecticide 95 
(Table 1). For pirimiphos methyl, there was only one survivor out of over 800 females tested. 96 
However, the 1% dose used is four times the standard recommended diagnostic concentration, 97 
and results are best interpreted as evidence that higher intensity resistance is absent, rather than 98 
the population being fully susceptible.   99 
The intensity of resistance to deltamethrin measured using adapted CDC bottle assays was 100 
extremely high in all villages (RR50 range 1441 to 2405) (Table 2 and Table S1A&B). There was 101 
no difference between villages (overlapping 95% confidence intervals of LD 50 values in Table 102 
2). 103 
Exposure to a pyrethroid-only LLIN (PermaNet 2.0) killed 100% of the susceptible An. gambiae 104 
Kisumu strain but fewer than 30% from any study village (Fig. 2). Though the correlation between 105 
net-induced mortality and resistance intensity to deltamethrin was not significant (ρ = 0.41, n = 106 
8, P = 0.32), the generally poor performance of the pyrethroid-only LLIN tested is consistent with 107 
the very high pyrethroid resistance in the villages. Mortality rates of mosquitoes exposed to LLIN 108 
material differed significantly between villages (Table 3).   109 
 110 
Species identification and target-site resistance 111 
 Overall, 975 randomly selected An. gambiae s.l., which comprised of unexposed and pyrethroid 112 
bioassay survivors, were identified to species by PCR.  A subset of these mosquitoes were 113 
screened for common resistance-linked kdr mutations in the voltage-gated sodium channel. The 114 
predominant malaria vector species in seven of the villages was An. gambiae (84-98%) with a 115 
single village (Kouakro) in which An. coluzzii and An. gambiae were found in comparable 116 
proportions (50%) (Table 4).  117 
The 1014S mutation was not detected in any of the 367 mosquito samples screened. The 1014F 118 
mutation was found at very high frequency (>0.9) whereas the 1575Y allele was present at low 119 
frequency (<0.15) in mosquito populations across villages. Allele frequencies of the 1014F 120 
mutation did not differ among villages (χ27 = 12.2, P = 0.59) (Table 5). Likewise, allele frequencies 121 
of the 1575Y mutation were very similar across villages (χ27 = 1.1, P = 0.99) (Table 5). The 122 
frequency of 1575Y also did not differ between unexposed mosquitoes and bioassay survivors 123 
(χ21 = 0.05, P = 0.82). In each village, neither locus showed significant deviation from Hardy-124 
Weinberg equilibrium (Table 5).  125 
There was significant variation in allelic frequency of the G119S polymorphism across villages 126 
(22% to 43%; χ27 = 22.75, P = 0.002), which essentially reflected variation in heterozygote vs 127 
susceptible homozygotes because resistant homozygotes were extremely rare (Fig. 3). Analysis 128 
of the qPCR dye balance ratio in heterozygotes, which can indicate variation in the relative 129 
number of duplicated serine alleles, showed no significant variation among villages in 130 
serine/glycine ratios (F1,7 = 0.94, P = 0.47), suggesting a similar copy number profile of serine 131 
alleles. There was no evidence that the frequency of G119S differed between An. coluzzii and An. 132 
gambiae in the mixed-species village of Kouakro (χ21 = 1.2, P = 0.27). 133 
Genome-wide transcription analysis 134 
Whole genome microarray experiments were conducted to identify candidate genes potentially 135 
involved in insecticide resistance in the dominant species An. gambiae collected from two of the 136 
study villages (N’Guessan Pokoukro and Sessenouan), in comparison with two susceptible 137 
strains, using a strict criterion for significance based on replicated fold change and multiple-138 
testing corrected P-value thresholds.  139 
Out of a total of 14,914 probes screened, 616 corresponding to 525 genes were significant 140 
according to the above filtering criteria (Fig. 4, Table S2A). Of the 267 genes (with 340 transcripts) 141 
over-expressed in all comparisons, we focused on those with known or putative links to 142 
detoxification or resistance more broadly, which comprised of 18 genes, including 11 cytochrome 143 
P450s, 3 glutathione S-transferases (GSTs), 2 carboxylesterases, an alcohol dehydrogenase, and 144 
peroxidase, a redox gene and transporters and cuticular genes (Table S2A). The three 145 
detoxification genes within the top 20 most over-expressed genes were cytochrome P450s (Table 146 
S2B) of which Cyp6P3 and Cyp9K1 exhibited >10-fold change and Cyp6M2 with ≥8 fold-change, 147 
but more variability across comparisons, relative to susceptible lab strains (Table S2B). Other 148 
highly over-expressed genes (within top 20) lack current description or have no putative link to 149 
insecticide resistance, based on current knowledge, such as the most highly expressed gene (h+ 150 
transporting atp synthase subunit: fold change >60). It is interesting to note that one of the two 151 
overexpressed esterases is the target site gene Ace-1 with average overexpression of almost 3-152 
fold, consistent with the expected presence of duplicated resistance alleles.  153 
Quantitative RT-PCR expression of candidate genes in selected villages 154 
Candidate genes chosen for further analysis using qRT-PCR included the most over-expressed 155 
detoxification genes (Cyp6P3, Cyp9K1, and Cyp6M2), the most overexpressed esterase COEA1F, 156 
and the redox partner gene cytochrome P450 reductase. A further P450, Cyp6Z3, was chosen 157 
because it was significant in 3 out of four comparisons and we wished to examine whether the 158 
stringency of our filtering might be excluding potential valid detoxification candidates. The 159 
validation also included two under-expressed genes; one meeting the significant threshold across 160 
all comparisons (GSTD11) and one that was strongly underexpressed in one population (Cyp9J5), 161 
providing additional variation for qPCR vs microarray validation.  162 
There was good agreement between qPCR and microarray estimates of gene expression (r2 = 0.73, 163 
P = 0.001) (Fig. S1). Fold change was generally higher in microarray results except for Cyp6P3 164 
and Cyp9K1, which showed higher expression in qPCR analysis. 165 
The expression levels of the eight chosen candidate genes were assessed for variation across the 166 
eight villages. There was significant variation in the level of expression of all genes among villages 167 
(Kruskal Wallis tests, maximum P < 0.01) (Fig. 5 & Table S4A). The highest general level of 168 
expression was for Cyp6P3; with a particular peak in the N’Guessan Pokoukro village (33-fold 169 
change) but much lower levels in some other villages. Interestingly, there was a significant 170 
correlation between fold change in Cyp6P3 and the intensity of resistance to deltamethrin (r2 = 171 
0.78, P = 0.023) (Fig. S2). Expression level of all screened genes did not differ between unexposed 172 
mosquitoes and those that survived exposures to deltamethrin and cyfluthrin (Fig. S3 & Table 173 
S4B).  174 
Discussion 175 
Insecticide resistance in African malaria vectors is one of the major challenges facing malaria 176 
control programmes. A better understanding of the prevalence, intensity and mechanisms of 177 
resistance could inform the development of resistance management strategies. Results from the 178 
present study, the first of its kind on An. gambiae s.s. from Côte d’Ivoire, demonstrate phenotypic 179 
variation at a small spatial scale likely underpinned by variation in resistance mechanisms, 180 
notably P450 expression level and variation in Ace-1 genotypic frequencies. 181 
Phenotypic resistance 182 
High prevalence of resistance was evident for all insecticides tested, with the exception of 183 
pirimiphos methyl which was tested at a higher than diagnostic dose. These results are consistent 184 
with findings from previous studies conducted in the same area21,32. Multiple insecticide 185 
resistance has been previously documented in An. coluzzii  from the southern part of the country 186 
(Tiassale)10,21. This observation is of significant concern for vector control, as resistance to non-187 
pyrethroids limits the options for pyrethroid resistance management.  188 
The intensity of deltamethrin resistance detected in the present study is among the highest 189 
reported to date in Anopheles mosquitoes. While quantitative measure of resistance enables 190 
detection of potential changes in resistance level in mosquito populations 33, intensity level 191 
associated with operational control failure has yet to be defined. Nevertheless, the poor 192 
performance of LLINs in WHO cone assays against the local Anopheles mosquitoes is consistent 193 
with the high resistance intensity recorded and is suggestive of a potential loss of community 194 
protection from pyrethroid-only LLINs in this area. 195 
Resistance mechanisms 196 
The molecular basis of the multiple insecticide resistance phenotype was investigated using 197 
microarray experiments performed on An. gambiae from two villages (one from each study arm). 198 
Analysis focused on overexpression of potential resistance-linked gene, but it should be noted 199 
that many genes of unknown function or no putative link to insecticide resistance were also 200 
significantly over-expressed in field mosquitoes compared to susceptible lab colonies. If this 201 
observation is reproducible, it could merit further investigation. Of the most highly 202 
overexpressed genes, Cyp6P3 and Cy6PM2 have been implicated repeatedly in pyrethroid 203 
resistance and also in resistance to carbamates in An. gambiae and/or An. coluzzii 10,34 and are 204 
known to metabolize pyrethroids.35 Overexpression of Cyp9K1 has been linked to pyrethroid 205 
resistance in An. gambiae s.l. from Cameroon12, Benin36 and Bioko Island37, and has also recently 206 
been validated as a pyrethroid and pyriproxyfen metabolizer37. This is the first report of 207 
significant over-expression of Cyp9K1 in Côte d’Ivoire, and the fold change in expression in 208 
mosquitoes from our study area is much higher than expression reported in previous studies36,37. 209 
The over-transcription of this set of P450s, coupled with the near fixation of Vgsc 1014F and the 210 
presence of the 1575Y mutations in the local malaria vectors, likely underpins the extreme 211 
resistance to pyrethroids and DDT in this part of Côte d’Ivoire. The carboxylesterase COEAE1F 212 
and the cytochrome P450 reductase (CPR) were among the significantly over-expressed 213 
detoxification candidates. Carboxylesterases can play a role in pyrethroid metabolism, for 214 
example when paired secondarily with P450s such as CYP6Z238 (to which the candidate CYP6Z3 215 
is extremely similar) and CPR is a redox partner for P450s and might also link with resistance39. 216 
These over-transcribed genes could have contributed to the high pyrethroid resistance observed. 217 
Although pyrethroid resistance in this population of mosquitoes is associated with both target 218 
site insensitivity and metabolic mechanisms, evidence from a recent study suggests that the latter 219 
resistance type is likely to account for the most extreme pyrethroid resistance intensity 220 
detected11. DDT resistance is often mediated by over-expression of Glutathione S transferases 221 
(GST) and kdr-based mechanisms. The absence of over-expressed GST indicates that the high DDT 222 
resistance might have been primarily due to 1014F and in some cases also 1575Y kdr mutations, 223 
perhaps coupled with overexpression of some genes less commonly associated with DDT 224 
resistance such as Cyp6M240. The resistance intensifying mutation 1575Y was detected at 225 
relatively low frequency (<15%) and found only in mosquitoes with the phenylalanine allele, 226 
confirming that this mutation only occurs on a 1014 haplotype background17. Originally identified 227 
in Burkina Faso, the 1575Y mutation is spreading across the continent and has been reported in 228 
West and Central Africa13,41. Understanding the key determinants behind the rapid increase in the 229 
prevalence of the 1575Y kdr allele could help slow or even stop the spread of this mutation. 230 
Further investigation is also needed to determine if the survival advantage associated with the 231 
co-occurrence of the 1575Y and 1014F34 mutations could negatively impact control efforts. The 232 
allelic frequency of this emerging gene should be closely monitored in areas where novel tools 233 
incorporating pyrethroids are deployed.  234 
Carbamate resistance is primarily mediated by acetylcholinesterase insensitivity (G119S) and 235 
elevated expression of certain P450s10. The high survival to bendiocarb is consistent with the high 236 
frequency of Ace-1 heterozygotes, which as shown by elevated Ace-1 expression are likely present 237 
in higher copy numbers which raises carbamate resistance10.  Cyp6P3 was also over-expressed 238 
and has been shown to generate a moderately bendiocarb-resistant phenotype via transgenic 239 
expression and to metabolize bendiocarb, albeit with low catalytic efficiency. Indeed, 240 
susceptibility to bendiocarb in An. gambiae mosquitoes from Bioko has been reported despite 241 
over-expression of Cyp6P328, and it may be that this is a mechanism of lesser importance. The role 242 
of Cyp6M2, which generates a much stronger resistance phenotype than Cyp6P3 via transgenic 243 
expression but does not metabolise bendiocarb remains unclear, but it is certainly plausible that 244 
both combine with Ace-1 copy number variation of resistant alleles to generate resistance 245 
phenotypes as observed in An. coluzzii from southern Côte d’Ivoire10.  246 
Overall the resistance mechanisms detected in the study area are similar to those of An. coluzzii 247 
from southern Côte d’Ivoire10. These vector populations are from the same country and 248 
potentially exposed to the same insecticide selection pressure; mainly from the use of pyrethroid 249 
treated nets and insecticides for crop protection2. However, the elevated expression of the 250 
pyrethroid and pyriproxyfen metabolizing enzyme CYP9K1 in this study was not reported in the 251 
Tiassale mosquitoes. It could be that the frequency of this gene was low and undetectable at the 252 
time the Tiassale mosquito was characterised (in 2014) and might have increased only recently. 253 
Fine scale variation 254 
The villages were all within 50 km radius away from the town of Bouaké and varied between a 255 
few km and a few tens of km apart. Yet, there was significant variation in both phenotypic data 256 
for all insecticides to which resistance was detected and in expression of all genes studied across 257 
villages. Monitoring of insecticide resistance in malaria vectors is often performed at large 258 
geographical scale. However, as seen in the present and previous studies42,43, variation in 259 
insecticide resistance can occur at small spatial scales. This result indicates the need to account 260 
for potential micro geographic variation during resistance surveys, rather than assuming broad-261 
scale homogeneity for which single sites can act as reliable sentinels. Although wide-ranging 262 
phenotypic testing programmes incorporating fine-scale testing are unlikely to be realistic for 263 
most programmes, variation detected by molecular marker-based surveillance could aid in 264 
identifying sites of interest which could be prioritised for phenotypic testing. Interestingly, 265 
Cyp6P3, which showed the highest expression and high variation among villages correlated 266 
positively with resistance intensity suggesting a useful gene expression assay to predict 267 
resistance intensity.  268 
 269 
Conclusion 270 
Results from this study are concerning given that anopheline mosquitoes from this part of Côte 271 
d’Ivoire have developed strong resistance to the main insecticides currently being used for 272 
malaria control. Metabolic genes that were found to be over-expressed in this study have 273 
previously been shown to metabolize some of the compounds being incorporated in new classes 274 
of bed nets. For example, a range of P450s, including those identified in the present study 275 
(Cyp6P3, Cyp6M2 and Cyp9K1) metabolize pyriproxifen - an insect growth regulator deployed in 276 
nets to sterilise pyrethroid resistant mosquitoes44. This is consistent with the poor performance 277 
of Olyset Duo, a permethrin plus pyriproxyfen mixture LLIN in experimental huts in these areas 278 
of Côte d’Ivoire45 and in a randomised controlled trial in Burkina Faso46 where these pyriproxifen 279 
metabolizing genes were also found11. Use of PBO co-treated LLINs could be a more promising 280 
option in this area, given the apparent importance of P450 overexpression, though careful 281 
evaluation of efficacy and durability will be required.  282 
The insecticide selected for use in the lethal house lure CRT is the pyrethroid beta-cyfluthrin47. 283 
This is because a previous study showed that the EaveTube technology delivers an overwhelming 284 
dose of insecticide causing high levels of mortality of even resistant mosquitoes47. The data from 285 
the current study provides baseline information to track whether this additional use of 286 
pyrethroids on top of LLINs in the trial area will lead to changes in phenotypic resistance and 287 
associated molecular mechanisms. 288 
 289 
 290 
Methods 291 
Study area and collection of mosquitoes 292 
This study was performed as part of a two-armed cluster randomized controlled trial (CRT) 293 
evaluating the impact of an intervention defined by the WHO Vector Control Advisory Group as a 294 
“Lethal House Lure”, which combines household screening (S) with a novel insecticide delivery 295 
system called In2Care EaveTubes (ET). The trial, which ran between May 2017 and May 2019 in 296 
central Côte d’Ivoire in the Gbèkè district, aimed to investigate whether the use of screening plus 297 
EaveTubes (SET) on top of universal coverage of LLINs (PermaNet 2.0), provides greater 298 
protection against malaria than LLINs alone. The design of the trial is described in Sternberg et 299 
al31 and involves 40 villages, half assigned to SET plus LLINs, and the other half allocated to LLINs 300 
alone. The study area is a pre-forest zone with a humid tropical climate and covers an area of 301 
9,136 km2 with a population of over one million people. Rice farming is the dominant form of 302 
subsistence agriculture and the presence of rice growing valleys across the region provides 303 
extensive breeding sites for anopheline mosquitoes. Malaria transmission is year-round with a 304 
peak during the rainy season (from May to October) 48,49.  305 
Eight study villages (four in each treatment arm) were selected for insecticide resistance 306 
monitoring, based on the availability of mosquito breeding sites for sampling (Fig. 6). A 307 
description of each sampling site is provided in Table 6. Mosquitoes were collected from each 308 
village using the dipping method from September 2016 to November 2016. Whenever possible, 309 
mosquito larvae were collected from at least two breeding sites spread out over the village, and 310 
collections from the same village were subsequently pooled. Larvae were transported to the 311 
insectary at the Institut Pierre Richet (IPR), fed on ground Tetramin fish food and reared to 312 
adulthood under ambient temperature. Emerging adult mosquitoes were kept in netted cages and 313 
maintained on 10% honey solution. All adult female mosquitoes were morphologically identified 314 
as An. gambiae s.l. using taxonomic keys. 315 
 316 
Insecticide susceptibility assays 317 
To assess the prevalence of resistance in Anopheles mosquitoes from the CRT area (central Côte 318 
d’Ivoire), WHO susceptibility tests were performed between September and November 2016 319 
using adult An. gambiae s.l. mosquitoes emerged from larvae collected in eight selected CRT 320 
villages. The pyrethroid insecticide, beta-cyfluthrin is the active deployed in the EaveTube47 321 
whereas deltamethrin is the insecticide in the LLIN (PermaNet 2.0). Bioassays were conducted 322 
using papers treated with diagnostic concentration of these two insecticides: 0.05% deltamethrin 323 
and 0.15% cyfluthrin. Additionally, susceptibility tests using paper impregnated with 4% DDT, 324 
0.1% bendiocarb and 1% pirimiphos methyl were performed to assess the level of resistance to 325 
all four classes of WHO approved neurotoxic insecticides. The mosquitoes tested were 2-3 day-326 
old adult female mosquitoes, emerged from larvae collected from study villages and reared in the 327 
insectary at IPR. Approximately 100 mosquitoes, in batch of 25, were exposed for 1h to 328 
insecticide-treated papers, and mortality was recorded 24h later. The same number of 329 
mosquitoes were exposed to untreated papers and served as control. Mosquitoes that survived 330 
exposure to either of the pyrethroids were monitored for an additional 24h, after which the 331 
survivors were preserved in RNA later for subsequent molecular testing. 332 
 333 
Resistance intensity assays 334 
To determine the intensity of resistance to pyrethroids in the local Anopheles mosquitoes, 335 
adapted CDC bottle assays were performed.  Since both interventions (LLIN and EaveTube) are 336 
treated with the same type of pyrethroids (pyrethroid type II), the intensity of pyrethroid 337 
resistance was determined using pyrethroid from one of these interventions. . Bottles were 338 
coated with a range of deltamethrin concentrations (7.81µg/mL to 1000µg/mL), producing a 339 
range of mortality rates between 0% and 100% in mosquitoes from the study villages. Each 340 
bioassay included a control bottle treated with only acetone. The susceptible An. gambiae Kisumu 341 
strain (SS) served as reference and was tested against dosage range 0.001µg/mL-0.5µg/mL. Two 342 
to three days old adult female mosquitoes were exposed for 1h at each concentration in four 343 
replicates of 25.  344 
 345 
WHO cone bioassay 346 
To determine the impact of resistance on susceptibility to the bed nets (PermaNet 2.0) deployed 347 
in the study area, standard cone bioassays were performed according to WHO procedures using 348 
adult female mosquitoes emerged from larvae collected from the eight study villages and the 349 
susceptible Kisumu strain. Approximately 60 mosquitoes were exposed to netting sample for 3 350 
min and the mortality rate was determined 24h later. Control mosquitoes (~60) were exposed to 351 
an untreated net and served as control.  352 
 353 
Species identification and target site resistance mechanisms  354 
To type mosquitoes to species and identify target site resistance mechanisms in Anopheles 355 
mosquitoes from study villages, genomic DNA was extracted from a pair of legs taken from field 356 
mosquitoes that survived exposure to deltamethrin and cyfluthrin in WHO cylinder assays, and 357 
from a subset of unexposed female mosquitoes. The legs were boiled in 20µL of buffer solution 358 
for 90 min at 95°C. The member of the An. gambiae complex were identified to species using SINE-359 
PCR 50. 360 
TaqMan PCR assays were used to screen mosquito samples for mutations in the voltage gated 361 
sodium channel, including the 1014S, 1014F and 1575Y17,51, and for the ace-1 G119S52 resistance 362 
mutation in acetylcholinesterase. Heterozygotes for An. gambiae and An. coluzzii are all expected 363 
to include duplications in some combination of (1) G and S alleles are paired on a single 364 
chromosome - a heterogeneous duplication (2), an unduplicated G allele, and (3) a multicopy S 365 
allele53. Variation in composition of G and duplicated S alleles can be detected quantitatively as a 366 
difference in dye balance in heterozygotes in TaqMan qPCR54. 367 
 368 
Whole genome microarray  369 
A genome-wide transcription profiling was performed to identify genes differentially expressed 370 
in mosquitoes from two CRT villages (one from each study arm) relative to susceptible lab strains. 371 
All of the villages involved in the CRT were at least 2km apart; however, to capture the whole 372 
range of over/under expressed genes in mosquitoes from the study area, two villages much 373 
further away from each other were selected for microarray analysis. Mosquitoes used in 374 
microarray studies were confirmed as An. gambiae using SINE-PCR. 375 
 376 
Gene expression profiles of unexposed, female An. gambiae mosquitoes from one control village 377 
(N’Guessan Pokoukro) and the survivors of deltamethrin exposure from one intervention village 378 
(Sessenouan) were compared to those of two susceptible lab strains, Anopheles gambiae Kisumu 379 
and Anopheles gambiae Ngousso, using an interwoven loop design (Fig. S4).  Inclusion of survivors 380 
from one village and unexposed from another, with the highest prevalence of pyrethroid 381 
resistance maximised chances of identifying resistance-associated candidate genes, whilst 382 
ensuring that overexpression induced primarily by exposure (i.e. gene induction) was precluded. 383 
Field-collected mosquitoes included in the microarrays analysis were solely the most 384 
predominant species, Anopheles gambiae. Significant differential expression between field 385 
mosquitoes from the two villages and the two insecticide susceptible lab strains was identified 386 
using a filtering approach. This was based on a P < 0.05 (after Bonferroni correction), a fold 387 
change in expression > 2 or <-2 and directionality i.e. the same direction of differential expression 388 
(upregulated or down-regulated) in the 4 comparisons (N’guessan Pokoukro vs Kisumu, 389 
N’guessan Pokoukro vs Ngousso, Sessenouan vs Kisumu, Sessenouan vs Ngousso). . Total RNA 390 
was extracted from batches of ten female An. gambiae mosquitoes using a PicoPure RNA isolation 391 
kit (Thermo Fisher Scientific) according to the manufacturer’s protocol. Total RNA extracted from 392 
mosquitoes was treated using DNase (RNase free DNase set, Qiagen Hilden Germany). Before 393 
further use, the concentration and quality of the extracted RNA were evaluated using a NanoDrop 394 
spectrophotometer (Thermo Fisher Scientific) and a 2100 Bioanalyzer (Agilent Technologies). 395 
Four biological replicate extractions of total RNA for each mosquito population or colony were 396 
amplified and labelled using the Low Input Quick Amp Labeling Kit (Agilent Technologies). The 397 
Agilent Agam15k array was used for dual-color hybridizations (N’guessan Pokoukro vs Kisumu, 398 
N’guessan Pokoukro vs Ngoussou, Sessenouan vs Kisumu, Sessenouan vs Ngoussou)55. The 399 
labelled samples were hybridized using a Gene Expression Hybridization Kit (Agilent 400 
Technologies). Washing, scanning and feature extraction were performed according to the 401 
manufacturer’s recommendations. The design of the microarray experiment was optimized 402 
through comparison of the above strains across four microarray slides.  403 
 404 
Quantitative reverse transcriptase PCR for candidate gene expression in field mosquitoes 405 
The expression of a subset of genes from microarray known to play a role in insecticide resistance 406 
in Anopheles gambiae mosquitoes was taken forward for validation and measurement in field 407 
mosquitoes from the eight villages using reverse-transcription quantitative PCR (RT-qPCR). For 408 
each village, the expression for each gene of interest was measured in three cohorts of 409 
mosquitoes: non-exposed, deltamethrin and cyfluthrin survivors. Prior to qPCR experiments, 410 
RNA was extracted from field mosquitoes and quantified using the Nanodrop spectrophometer. 411 
cDNA was subsequently synthesized from 11g of RNA using oligo(dT) 20 (50 μM) and SuperScript 412 
III (200U) (Invitrogen) and purified through a DNA-binding column (Qiagen). Three pairs of 413 
primers of each target gene were designed using Primer-BLAST tool (NCBI: 414 
http://www.ncbi.nhi.gov/tools/primers-blat/). The primer pair with the highest efficiency value 415 
(~100%), determined by running standard qPCR using serial dilution of a single cDNA sample, 416 
was selected for subsequent qPCR (details of the primers are given in Table S3). For each qPCR 417 
reaction, four biological replicates of each treatment group and two technical replicates were 418 
used. QPCR was performed using an Agilent Mx3005P QPCR System and the cycling condition 419 
was as follow: 95°C for 3 min, 40 cycles of 95°C for 10 s and 60°C for 10 s. Expression of the genes 420 
was normalized using references genes (Ribosomal S7 and Elongation Factor).  421 
Statistical analysis 422 
Mosquito mortality rates were compared using Generalized linear models with a binary link 423 
function in SPSS v23. WHO assessments of mortality rates are: less than 90% indicates resistance; 424 
higher than 98% indicates susceptibility: between 90 and 98% requires further testing to confirm 425 
resistance status56.  The intensity of resistance (Resistance Ratio, or RR50) was estimated using 426 
the R statistical software version 2.15.0 to compare the LD50 of the wild population relative to 427 
that of the susceptible lab strain. The variation in bioassay mortality rates of An. gambiae 428 
mosquitoes between villages was tested using Generalised Linear Model (GLM). The spearman 429 
test was used to test the correlation between resistance intensity to deltamethrin and bioassay 430 
mortality rates. The frequencies of target site resistance mutations in field anopheline 431 
populations were compared between study villages using a χ2-square test with Yates continuity 432 
correction. Concordance with Hardy-Weinberg equilibrium was assessed for each resistance 433 
marker in each village using the permutation-based probability test in Genepop57,58, with 434 
Bonferroni correction applied for multiple testing. 435 
 A MAANOVA model was used to analyse microarray data using previously described custom R-436 
scripts55. Differentially expressed genes (over/under expressed) were those with a fold change 437 
consistently greater than 2 or less than -2 across the four comparisons (N’guessan Pokoukro vs 438 
Kisumu, N’guessan Pokoukro vs Ngousso, Sessenouan vs Kisumu, Sessenouan vs Ngousso) and 439 
with a significant Bonferroni-corrected p value in all four comparisons. 440 
Outliers were identified and excluded from the qPCR dataset prior to analysis. The ΔΔCt method 441 
incorporating PCR efficiency was used to compare expression of each target gene between field 442 
mosquitoes and the lab strain59. Significant difference in fold change between field samples and 443 
the reference lab colony was estimated using a t-test (P < 0.05). Kruskal Wallis test was used to 444 
compare the level of expression of candidate genes across the three groups of field mosquitoes 445 
(unexposed group and mosquitoes surviving exposure to the two different pyrethroids in WHO 446 
cylinder assays).  447 
 448 
Data availability 449 
All data generated or analysed during this study are included in this published article (and its 450 
Supplementary Information files) 451 
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Fig. 1 Twenty-four-hour percentage mortality of An. gambiae from each village exposed in 
diagnostic bioassays to A) 0.05% deltamethrin, B) 0.15% cyfluthrin, C) 0.1% bendiocarb, 
D) 4% DDT and E) 1% pirimiphos methyl. Error bars represent 95% Cis and the dotted 
line indicates WHO resistance threshold.  
 
  
Table 1: Generalised linear model testing the effects village on bioassay mortality for 
each insecticide 
 
 
 
 
 
 
 
        
   Village (arm)   
  Wald χ2 df P 
deltamethrin 35.245 6 0.000004 
cyfluthrin 25.53 6 0.0003 
bendiocarb 14.52 6 0.024 
DDT 18.03 6 0.006 
pirimiphos methyl not calculated because mortality near 100% 
Table 2: Intensity of resistance to deltamethrin in An. gambiae from different villages in 
the study area prior to the study. 
                     *Susceptible reference strain;  
                     LD: lethal doses expressed in μg/mL;  
                   RR50: Resistance ratio, calculated by dividing the LD50 of the field mosquito population by that 
of the susceptible reference strain 
  
 
Table 3: Generalised linear model testing the effects of village on net induced mortality  
 
  Village (arm)   
  Wald χ2 df  P 
PermaNet 2.0       20.87 7  0.004 
 
 
 
 
 
 
 
 
 
Strain Slope (SE) LD 50 (95% CI) LD 95 (95% CI) RR50  
Kisumu* 1.3 (0.18) 0.015 (0.009-0.022) 0.261 (0.136-0.767) 
              
     -         
     
Akanzakro 1.7 (0.2) 27.2 (20.3-35.2) 250.1 (166.7-451.-0) 1873  
 
Kologonouan 1.5 (0.1) 21.9 (15.8-28.5) 289.3 (190.0-534.4) 1504  
 
Konzo 1.6 (0.1) 23.5 (19.1-28.3) 237.4 (173.7-358.2) 1617  
 
Kouakro 1.7 (0.17) 22.4 (17.3-28.0) 213.5 (145.0-376.6) 1542  
 
N’Guessan Pokoukro 2.1 (0.2) 33.7 (25.7-43.2) 207.0 (139.6-377.6) 2314  
 
Saoundi 1.7 (0.1) 35.0 (28.9-41.9) 322.4 (237.8-477.3) 2405  
 
Seoule  1.7 (0.1) 21.0 (17.2-25.0) 183.0 (139.1-261.3) 1441  
 
Sessenouan 1.4 (0.1) 27.4 (20.8-34-8) 390.3 (256.3-708.0) 1883  
Table 4: Species composition in the study villages 
Study villages Anopheles 
gambiae (N) 
Anopheles 
coluzzii (N) 
Hybrids (N) 
Akanzakro 117 0 2 
Kologonouan 86 0 0 
Konzo 99 2 0 
Kouakro 53 53 0 
N’Guessan Pokoukro 160 12 1 
Saoundi 116 2 0 
Seoule 99 1 1 
Sessenouan 158 12 1 
N: number of Anopheles gambiae mosquitoes identified to species by SINE-PCR 
 
 
Table 5: Frequencies of 1014F and 1575Y kdr alleles in Anopheles gambiae from study villages. 
N: number of samples, L: leucine, F: phenylalanine, N: asparagine, Y: tyrosine. P values are from χ2-squared 
tests 
 
Study villages N tested L1014F      N1575Y     
P value    LL LF FF F (1014F) P value   NN NY YY F (1575Y) 
Akanzakro 47 0 0 47 1 0.59  36 11 0 0.12 0.32 
Kologonouan 46 0 1 45 0.99   38 6 2 0.11  
Konzo 48 0 4 44 0.96   35 13 0 0.14  
Kouakro 45 0 9 36 0.90   36 9 0 0.10  
N'Guessan Pokoukro 47 0 5 42 0.95   37 10 0 0.11  
Saoundi 41 1 4 36 0.93   34 6 1 0.11  
Seoule  40 1 1 38 0.96   31 8 1 0.13  
Sessenouan 53 0 0 53 1    43 9 1 0.10  
 Fig. 2 Percentage mortality of susceptible Kisumu and resistant Anopheles gambiae 
exposed to LLIN material in WHO cone bioassays. Error bars indicate 95% Cis. 
 
 
 Fig. 3 Genotypic frequencies of the Ace-1 G119S mutation in Anopheles gambiae 
mosquitoes. GG: Homozygote wild type; GS: Heterozygote resistant, SS: homozygote resistant 
 Fig. 4 Differentially expressed probes in Anopheles gambiae s.s. from two villages 
compared to two susceptible lab colonies. Average log2-transformed fold-differences are 
plotted against average negative log probabilities. Probes from genes chosen for qPCR validation 
are labelled. 
 
  
     Fig. 5 Box-whisker plots show mean fold difference in expression of candidate genes (relative to susceptible colony samples) across     
villages. The boxes represent the 25% and 75% quartiles and the whiskers indicate 5% - 95% quartile ranges. The horizontal line within each box 
represents the mean fold difference in gene expression, and the dots denote outliers
   
Fig. 6 Map showing study villages involved in insecticide resistance monitoring (rm) 
 
 
Table 6: Location of study villages and description of mosquito breeding habitats. 
SET: Screening plus EaveTube, LLIN: long-lasting insecticidal net. 
 
 
     
Study village Geographic coordinates Arm Type of breeding habitats 
  Longitude Latitude     
N'Guessan Pokoukro (NP) 7°56’N   5°20’W Control (LLIN) Water puddle 
Kologonouan (Kolo) 7°66’N  5°17’W Control (LLIN) Water puddle 
Konzo (Kon) 7°46’N   5°07’W Control (LLIN) Vegetable farm + rice field 
Seoule Ahounzè (Seou) 7°76’N 5°42’W Control (LLIN) Rice field 
Sessenouan (Sesse) 7°69’N  5°17’W SET and LLIN Vegetable farm + rice field 
Kouakro (Koua) 7°83’N   5°08’W SET and LLIN Rice field + water puddle 
Saoundi (Saou) 7°78’N   5°26’W SET and LLIN Rice field 
Akazankro (Akan) 7°62’N  5°09’W SET and LLIN Vegetable farm + rice field 
Supplementary files 
Figure S1: Side-by-side fold change in gene expression measured by microarrays and qRT-
PCR for selected candidate genes. The overall correlation is r2= 0.73.  
Figure S2: Association between fold change in Cyp6P3 and resistance intensity to 
deltamethrin 
Figure S3: Boxplots show mean fold change in expression of candidate genes across 
treatments. The boxes represent the 25% and 75% quartiles and the whiskers indicate 5% - 
95% quartile ranges. The horizontal line within each box represents the mean fold difference in 
gene expression and the dots denote outliers. 
Figure S4: Interwoven microarray loop design comparing field mosquito samples from two 
CRT villages (one control cluster: np=N’guessan Pokoukro and one intervention cluster: 
se=Sessenouan) and two lab colonies (kis= An. gambiae Kisumu and ng= An. gambiae 
N’goussou). Each circle represents mRNA extracted from a pool of 10 female An. gambiae s.s.  
Individuals microarrays are represented by arrows (32 in total). The direction of the arrows 
indicates dye labelling. 
Table S1: Twenty-four-hour mortality of A) Anopheles gambiae Kisumu and B) Anopheles 
gambiae from each study village after exposure to a range of deltamethrin concentration 
in adapted CDC bottle assay. 
Table S2: Microarray results (.xlsx). TableS2A: Microarray results for all probes. Table S2B: 
Subset of microarray results showing genes significantly overexpressed and sorted by average 
pairwise fold change 
Table S3: Details of primers used in qRT-PCR analysis (.xlsx) 
Table S4: Statistical results on comparison of fold change in gene expression among chosen 
CRT villages (Table S4A) and between treatments (Table S4B)  
